Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20


Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals.

Funston G, O'Flynn H, Ryan NAJ, Hamilton W, Crosbie EJ.

Adv Ther. 2018 Apr;35(4):577-589. doi: 10.1007/s12325-018-0683-3. Epub 2018 Mar 7. Erratum in: Adv Ther. 2018 Apr 4;:.


Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.

Greville G, McCann A, Rudd PM, Saldova R.

Epigenetics. 2016 Dec;11(12):845-857. Epub 2016 Sep 30. Review.


The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer.

Erondu CO, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Peters E, Schwartz AG, Terry PD, Wallace K, Akushevich L, Wang F, Crankshaw S, Berchuck A, Schildkraut JM, Moorman PG.

J Womens Health (Larchmt). 2016 Jun;25(6):571-8. doi: 10.1089/jwh.2015.5359. Epub 2016 Feb 17.


Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.

Lim A, Mesher D, Gentry-Maharaj A, Balogun N, Widschwendter M, Jacobs I, Sasieni P, Menon U.

BJOG. 2016 May;123(6):1012-20. doi: 10.1111/1471-0528.13447. Epub 2015 May 29.


Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Schrepf A, Lutgendorf SK, Pyter LM.

Brain Behav Immun. 2015 Oct;49:1-17. doi: 10.1016/j.bbi.2015.04.010. Epub 2015 May 6. Review.


In 2014, can we do better than CA125 in the early detection of ovarian cancer?

Cohen JG, White M, Cruz A, Farias-Eisner R.

World J Biol Chem. 2014 Aug 26;5(3):286-300. doi: 10.4331/wjbc.v5.i3.286. Review.


Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.

Gooden MJ, Wiersma VR, Boerma A, Leffers N, Boezen HM, ten Hoor KA, Hollema H, Walenkamp AM, Daemen T, Nijman HW, Bremer E.

Br J Cancer. 2014 Mar 18;110(6):1535-44. doi: 10.1038/bjc.2014.55. Epub 2014 Feb 11.


Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.

Pitta Dda R, Sarian LO, Barreta A, Campos EA, Andrade LL, Fachini AM, Campbell LM, Derchain S.

BMC Cancer. 2013 Sep 18;13:423. doi: 10.1186/1471-2407-13-423.


Global ovarian cancer health disparities.

Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM.

Gynecol Oncol. 2013 Apr;129(1):258-64. doi: 10.1016/j.ygyno.2012.12.016. Epub 2012 Dec 22. Review.


Symptoms and risk factors of ovarian cancer: a survey in primary care.

Gajjar K, Ogden G, Mujahid MI, Razvi K.

ISRN Obstet Gynecol. 2012;2012:754197. doi: 10.5402/2012/754197. Epub 2012 Aug 23.


Irritable bowel syndrome--the main recommendations.

Andresen V, Keller J, Pehl C, Schemann M, Preiss J, Layer P.

Dtsch Arztebl Int. 2011 Nov;108(44):751-60. doi: 10.3238/arztebl.2011.0751. Epub 2011 Nov 4.


Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.

Goff BA, Lowe KA, Kane JC, Robertson MD, Gaul MA, Andersen MR.

Gynecol Oncol. 2012 Feb;124(2):230-5. doi: 10.1016/j.ygyno.2011.10.032. Epub 2011 Nov 6.


Intention to seek care for symptoms associated with gynecologic cancers, HealthStyles survey, 2008.

Trivers KF, Rodriguez JL, Hawkins NA, Cooper CP, Polonec L, Gelb CA.

Prev Chronic Dis. 2011 Nov;8(6):A144. Epub 2011 Oct 17.


Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis.

Lurie G, Wilkens LR, Thompson PJ, Matsuno RK, Carney ME, Goodman MT.

Gynecol Oncol. 2010 Nov;119(2):278-84. doi: 10.1016/j.ygyno.2010.05.028. Epub 2010 Jun 29.


Predictive value of symptoms for early detection of ovarian cancer.

Rossing MA, Wicklund KG, Cushing-Haugen KL, Weiss NS.

J Natl Cancer Inst. 2010 Feb 24;102(4):222-9. doi: 10.1093/jnci/djp500. Epub 2010 Jan 28.


A hospital-based case-control study of identifying ovarian cancer using symptom index.

Kim MK, Kim K, Kim SM, Kim JW, Park NH, Song YS, Kang SB.

J Gynecol Oncol. 2009 Dec;20(4):238-42. doi: 10.3802/jgo.2009.20.4.238. Epub 2009 Dec 28.


Risk of ovarian cancer in women with symptoms in primary care: population based case-control study.

Hamilton W, Peters TJ, Bankhead C, Sharp D.

BMJ. 2009 Aug 25;339:b2998. doi: 10.1136/bmj.b2998.


Prediagnostic symptoms of ovarian carcinoma: a case-control study.

Lurie G, Thompson PJ, McDuffie KE, Carney ME, Goodman MT.

Gynecol Oncol. 2009 Aug;114(2):231-6. doi: 10.1016/j.ygyno.2009.05.001. Epub 2009 May 22.


Identifying symptoms of ovarian cancer: a qualitative and quantitative study.

Bankhead CR, Collins C, Stokes-Lampard H, Rose P, Wilson S, Clements A, Mant D, Kehoe ST, Austoker J.

BJOG. 2008 Jul;115(8):1008-14. doi: 10.1111/j.1471-0528.2008.01772.x.

Supplemental Content

Support Center